Read more
9:53 PM · 4 June 2024

Centrus Energy drops 5% despite perspectives of taking over US uranium enrichment market

Centrus Energy
Stocks
LEU.US, Centrus Energy Corp - class A
-
-

Top US uranium enriching company Centrus Energy (LEU.US) drops today almost 5% as Wall Street sell stocks related with hard commodities, today. Despite on that company, market cap is today near $700 million, while Centrus holds more than $200 million in cash and its equivalent and has been able to increase Q4 2023 net profit from to $84.4 million from $52.2 million during Q4 2022. The company still expects to boost new contracts orders book to $1 billion long-term.  In 2023 Centrus generated revenue of $320 million vs $293.8 million for the whole 2022 year. In the Q4 2023 Centrus long-term debt dropped to $89 million vs $95 million in Q4 2022. In a whole, 2023 global nuclear power generation grew 8% and also higher U308 uranium prices signals increasing demand. 

  • Centrus is based in Maryland (US) and is the only American uranium enricher, who has ambition to take over US market during recent decades controlled by Russian Rosatom operations. As for now, Russia holds approximately 45% of the world’s uranium-enrichment market, according to the US Department of Energy analysis. What's more, it supplies nearly 25% of enriched uranium used in US nuclear sector.
  • In May, President Biden signed a bipartisan document to ban the import of Russian low-enriched uranium (LEU), which may be at least medium term catalyst for Centrus Energy (LEU.US) business, as US relations with Rosatom crumbles due to geopolitical tensions.
  • Company will produce both LEU and future reactors HALEU fuel. In November 2022, US Department of Energy (DoE) passed $150 million to make the company produce high quality enriched uranium fuel needed to power the next generation of reactors. As for now, Centrus enrichment plant is the only American facility licensed to produce it.

Centrus CEO, Vexler commented that: "Getting the amount of funding that’s been allocated is a great accomplishment. With the continued support of the government and a public–private partnership, we will bring enrichment and all the associated benefits back to the U.S.” Centrus facility began HALEU enrichment in Q4 2023, as the first U.S.-owned enrichment plant to start production in the last 7 decades. 

Centrus Energy (D1 interval)

On the chart we can see potentially bearish head and shoulders pattern and stock reacted with declines at 23.6 Fibo level, near $52 per share. On the other hand, also during Q2 2023 stock was traded below SMA200 and it didn't stopped investors appetite.

31 October 2025, 2:47 AM

Amazon and Apple beat estimates. Will it lift Wall Street higher?

31 October 2025, 12:45 AM

Apple slightly gains after earnings 🗽China sales misses estimates

31 October 2025, 12:26 AM

Amazon gains almost 10% after earnings report 📈US100 tries to recover

30 October 2025, 10:24 PM

Eli Lilly after Earnings: High expectations, even higher results.

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.